Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...

But some nouns are “uncountable”. These are things that are a concept, or not easy to divide. In general, we do not make them plural, or say how many we have.